Platelet Function Testing Explained: When and Why It’s Performed

Platelet function testing plays a pivotal role in understanding how platelets behave across various clinical and research settings.

While routine coagulation tests focus on clotting factors (secondary haemostasis), platelet function testing assesses how platelets respond to stimuli, become activated, and form aggregates (primary haemostasis).

This provides a more complete picture of haemostasis and supports more informed decision-making in both research and clinical contexts.

What are platelets and why do they matter?

Platelets are one of the main components of blood and play a key role in stopping bleeding. They are not complete cells, but small fragments derived from larger cells in the bone marrow called megakaryocytes.

In an event of vascular injury, platelets are among the first responders, forming a plug that prevents excessive bleeding.

At the same time, platelet activity must be carefully balanced. Excessive activation can contribute to thrombosis, while reduced function can increase bleeding risk.

Platelet activation is a dynamic process. Upon stimulation, platelets change shape, release signalling molecules, and bind together to form aggregates. This coordinated response is what platelet function testing aims to assess.

What is platelet function testing?

Platelet function testing refers to a group of methods used to evaluate how platelets respond to different stimuli under controlled conditions.

Rather than simply measuring whether clotting occurs, these tests focus on platelet behaviour, particularly their ability to activate and aggregate in response to specific agonists such as ADP, Arachidonic Acid, or TRAP.

This provides valuable insight into how platelets function in both normal and altered states.

How is platelet function measured?

Platelet function testing typically focuses on aggregation, where platelets bind together after being activated by different agonists, depending on what is being tested.

Different methods are available. Some use platelet-rich plasma (LTA), while others assess function directly in whole blood. Each approach provides different insights and may influence how platelet function is interpreted.

One commonly used method is whole blood impedance aggregometry. This technique measures changes in electrical impedance as platelets adhere to electrodes and form aggregates. As aggregation increases, electrical resistance changes, allowing platelet activity to be measured.

To explore how this method works in more detail, you can read our overview of whole blood impedance aggregometry here.

Understanding how these methods work helps put results into context and highlights why different approaches may not always produce identical outcomes.

When is platelet function testing performed?

Platelet function testing is used in a range of situations, including acquired or inherited platelet disorders, where platelet activity may influence outcomes or support decision-making.

Monitoring antiplatelet therapy
Antiplatelet medications are widely used to reduce thrombotic risk, particularly in cardiovascular disease and stroke, including in patients receiving stents. In many of these cases, patients are treated with dual antiplatelet therapy (DAPT), typically combining aspirin with a P2Y12 inhibitor.

Some patients may show reduced responsiveness, known as high platelet reactivity, while others may be more sensitive to treatment, increasing their risk of bleeding. Platelet function testing can provide additional insight into how a patient is responding and may help guide decisions around escalation or de-escalation of therapies such as P2Y12 inhibitors.

Percutaneous coronary intervention (PCI) and cardiovascular risk
In patients undergoing percutaneous coronary intervention (PCI), platelet reactivity plays an important role.

High platelet reactivity, or insufficient inhibition, can increase the risk of thrombosis, while excessive inhibition may increase bleeding risk. Platelet function testing can help guide treatment by showing how platelets are responding and supporting more tailored dual antiplatelet therapy (DAPT).

Cardiac surgery and peri- and postoperative care
Platelet function testing can also be relevant in surgical settings, particularly in patients receiving antiplatelet therapy.

Assessing platelet function may help identify patients at higher risk of bleeding and support decisions around transfusion and haemostatic management.

Platelet disorders and transfusion
Platelet function testing is also used in the investigation of suspected platelet function disorders.

It can also be applied to assess the functional quality of platelet concentrates used in transfusion, helping to ensure they provide effective haemostatic support.

Important considerations

While platelet function testing provides valuable insights, results can be influenced by several factors.

Pre-analytical variables, including sample handling, timing, and preparation, can affect outcomes. Natural biological variability also means that platelet responses can differ between individuals and even within the same individual over time.

Differences between testing methods can further contribute to variation in results and should be considered when comparing data or interpreting findings.

Understanding these factors is essential for ensuring accurate interpretation and meaningful application of platelet function testing.

Conclusion

Platelet function testing provides insight into platelet activity that is not captured by routine coagulation assays.

By assessing how platelets respond to different stimuli, it helps build a clearer picture of their role in both normal haemostasis and in conditions where activity is either reduced, increasing bleeding risk, or excessive, as seen in thrombosis.

This supports more informed decision-making in therapy monitoring, surgical care, and the investigation of platelet-related conditions.

As interest in platelet function continues to grow, these approaches are becoming increasingly important in advancing how platelet activity is understood and applied in practice.

If you’d like to learn more about the next generation of platelet function testing, explore our IMPACT overview page.

References

Michelson AD.
Platelets. 4th ed.

Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Invest. 2005 Dec;115(12):3378-84. doi: 10.1172/JCI27196. PMID: 16322783; PMCID: PMC1297269.

Tóth O, Calatzis A, Penz S, Losonczy H, Siess W. Multiple electrode aggregometry: a new device to measure platelet aggregation in whole blood. Thromb Haemost. 2006 Dec;96(6):781-8. PMID: 17139373.

Practical Haemostasis.
Platelet function testing: introduction

Aradi D, Komócsi A, Price MJ, Cuisset T, Ari H, Hazarbasanov D, Trenk D, Sibbing D, Valgimigli M, Bonello L; Tailored Antiplatelet Treatment Study Collaboration. Efficacy and safety of intensified antiplatelet therapy on the basis of platelet reactivity testing in patients after percutaneous coronary intervention: systematic review and meta-analysis. Int J Cardiol. 2013 Sep 1;167(5):2140-8. doi: 10.1016/j.ijcard.2012.05.100. Epub 2012 Jun 15. PMID: 22704866.

Ranucci M, Baryshnikova E, Soro G, Ballotta A, De Benedetti D, Conti D; Surgical and Clinical Outcome Research (SCORE) Group. Multiple electrode whole-blood aggregometry and bleeding in cardiac surgery patients receiving thienopyridines. Ann Thorac Surg. 2011 Jan;91(1):123-9. doi: 10.1016/j.athoracsur.2010.09.022. PMID: 21172499.

Angiolillo DJ, Galli M, Alexopoulos D, Aradi D, Bhatt DL, Bonello L, Capodanno D, Cavallari LH, Collet JP, Cuisset T, Ferreiro JL, Franchi F, Geisler T, Gibson CM, Gorog DA, Gurbel PA, Jeong YH, Marcucci R, Siller-Matula JM, Mehran R, Neumann FJ, Pereira NL, Rizas KD, Rollini F, So DYF, Stone GW, Storey RF, Tantry US, Berg JT, Trenk D, Valgimigli M, Waksman R, Sibbing D. International Consensus Statement on Platelet Function and Genetic Testing in Percutaneous Coronary Intervention: 2024 Update. JACC Cardiovasc Interv. 2024 Nov 25;17(22):2639-2663. doi: 10.1016/j.jcin.2024.08.027. PMID: 39603778.

Larsen JB, Hvas AM, Hojbjerg JA. Platelet Function Testing: Update and Future Directions. Semin Thromb Hemost. 2023 Sep;49(6):600-608. doi: 10.1055/s-0042-1757898. Epub 2022 Nov 16. PMID: 36384230.

Baker P, Platton S, Gibson C, Gray E, Jennings I, Murphy P, Laffan M; British Society for Haematology, Haemostasis and Thrombosis Task Force. Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis. Br J Haematol. 2020 Nov;191(3):347-362. doi: 10.1111/bjh.16776. Epub 2020 Jun 14. PMID: 32537743.

Bonello L, Tantry US, Marcucci R, Blindt R, Angiolillo DJ, Becker R, Bhatt DL, Cattaneo M, Collet JP, Cuisset T, Gachet C, Montalescot G, Jennings LK, Kereiakes D, Sibbing D, Trenk D, Van Werkum JW, Paganelli F, Price MJ, Waksman R, Gurbel PA; Working Group on High On-Treatment Platelet Reactivity. Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate. J Am Coll Cardiol. 2010 Sep 14;56(12):919-33. doi: 10.1016/j.jacc.2010.04.047. PMID: 20828644.

The references listed support the general principles described in this blog. Access to full publications may depend on journal availability.